The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Dose adjustments for products used in combination
-
Is it permissible to reference two separate product monographs (Product X and Product Y) for dose adjustments in a special population, if Product X is indicated for use with Product Y, and the Product X PM say to refer to the Product Y PM for dose adjustment of Product Y?
-
Is it permissible to reference two separate product monographs (Product X and Product Y) for dose adjustments in a special population, if Product X is indicated for use with Product Y, and the Product X PM say to refer to the Product Y PM for dose adjustment of Product Y?
Hey @Username,
Yes. As long as the dosing is consistent with both PM’s as described above.
